• A
  • A
  • A
  • ABC
  • ABC
  • ABC
  • А
  • А
  • А
  • А
  • А
Regular version of the site
Language Proficiency
English
Contacts
Phone:
15093
E-mail:
Address: 7 Vavilova Ulitsa, room 305
Timetable
Download CV
SPIN-RSCI: 4443-3967
ORCID: 0000-0002-7900-5810
ResearcherID: T-3068-2019
Scopus AuthorID: 57192713433
Google Scholar
Office hours
09:00 - 18:00
Supervisors
A. Tonevitsky
D. Maltseva
Printable version

 

Have you spotted a typo?
Highlight it, click Ctrl+Enter and send us a message. Thank you for your help!
To be used only for spelling or punctuation mistakes.

Sergey Nikulin

  • Sergey Nikulin has been at HSE University since 2020.

Education

  • 2019

    Doctoral programme in Biology
    Moscow Institute of Physics and Technology

  • 2015

    Master's in Applied Mathematics and Physics
    Moscow Institute of Physics and Technology

  • 2013

    Bachelor's in Applied Mathematics and Physics
    Moscow Institute of Physics and Technology

Courses (2020/2021)

Bioinformatics (Bachelor’s programme; Faculty of Biology and Biotechnology; 2 year, 3, 4 module)Rus

Publications16

Timetable for today

Full timetable

Higher School of Economics (NRU HSE) researchers with colleagues from the Far Eastern Federal University (FEFU) are creating a test system to study the toxicity of drugs and their permeability through the intestines. Universities equally finance joint research projects within the framework of the Mirror Laboratories competition, initiated by the Higher School of Economics

International Laboratory of Microphysiological Systems of the National Research University Higher School of Economics staff with their colleagues from the Laboratory of Microphysiological Systems from FEFU are going to create an innovative microfluidic test platform "intestines on a chip". With the use of this platform, scientists propose to study in real time the interaction of biologically active molecules with intestinal tissues and assess the toxicity and permeability of drugs through the barrier tissue of the small intestine. Due to this development, it would be possible to move away from ethically questionable and resource-intensive drug testing on animals and humans.